UBS Maintains Buy on Baldwin Insurance, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Neutral 48.4%

Neg 0% Neu 48.4% Pos 0%

UBS analyst Brian Meredith maintains Baldwin Insurance (NASDAQ:BWIN) with a Buy and lowers the price target from $40 to $35.